Joslin Diabetes Center
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Joslin Diabetes Center sits in the top decile of US sponsors by registered trial count (#295 of 15,742 sponsors by registered trial count).
Joslin Diabetes Center: 73 sponsored US clinical trials, 7 recruiting.
Joslin Diabetes Center sponsors 73 registered US clinical trials on ClinicalTrials.gov, 7 of them currently recruiting, and 56 completed. 6 of these trials are in Phase 3-4 (later-stage) and 8 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypoglycemia, with 6 trials.
Top-decile sponsor footprint
Joslin Diabetes Center ranks in the top decile of sponsors by registered trial count (#295 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
56 of 59 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (94.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
73 total, page 2 of 2
Simplified Insulin Protocol Using Lantus in Elderly
NCT01480843
Blood/Interstitial Glucose Measurements and Cognitive Function During Hypoglycemia and Recovery
NCT01283126
Effect of Dietary Fat on Glycemic Control in Type 1 Diabetes
NCT01292590
Evaluation of Intra-Abdominal Fat in Patients With Type 2 Diabetes Using a Non-Invasive Method
NCT01283113
Pramlintide (Symlin) for the Treatment of Hypoglycemia Following Gastric Bypass Surgery
NCT01841359
Surgery or Lifestyle With Intensive Medical Management in the Treatment of Type 2 Diabetes
NCT01073020
Using Conversation Maps to Reinforce Self-Care
NCT00895986
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
NCT00799643
Targeting Inflammation Using Salsalate in CardioVascular Disease
NCT00624923
Vitamin D and Coronary Calcification Study
NCT00752102
Imaging Inflammation in Autoimmune Diabetes
NCT00585936
Identifying and Overcoming Barriers to Diabetes Management in the Elderly: A Cost-effective Intervention Study
NCT01486290
Glycemic Stability of Insulin Aspart Versus Insulin Lispro in Insulin Pump Therapy
NCT00428207
Identifying and Overcoming Barriers to Diabetes Management in the Elderly: An Intervention Study
NCT01480804
Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)
NCT00392678
The Effect of Exenatide Compared to Lantus Insulin on Vascular Function in Type 2 Diabetes
NCT00353834
Changes in Inflammatory State in Asian Americans Changing From Traditional Asian Diets to American Diet - a Pilot Study
NCT00379548
Feasibility Study of Digital Photography and Group Discussion for People With Diabetes
NCT00225888
The Study of Inflammation on Blood Glucose Levels in Obese People
NCT00258115
Endothelial Function in Young Hispanic Adults at Risk for Type 2 Diabetes
NCT01926938
Intensive Care Program for Youth With Diabetes
NCT00961974
Optimizing Adherence and Glycemia in Youth With New Insulin-dependent Diabetes Mellitus (IDDM)
NCT00745342
Anti-Nephropathic Effects of Chronic Intermittent Intravenous Insulin Therapy (CIIIT)
NCT00594152
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 7 |
| Phase 3 | 1 |
| Phase 4 | 5 |
Therapeutic Areas
What is open in the Joslin Diabetes Center pipeline
7 recruiting of 73 indexed (10% open); 56 completed (77%).
Phase mix: 6 late (III/IV) vs 8 early (I/II) (balanced across stages).
Top condition: Hypoglycemia (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Joslin Diabetes Center: open-pipeline peers nationwide
Peers matched on 73 registered trials and 10% open enrollment, not the therapeutic-area sidebar.
Joslin Diabetes Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 73 trials (± recruiting share)
- Denver Health and Hospital Authority · 73 trials · 5% recruiting
- Hugo W. Moser Research Institute at Kennedy Krieger · 73 trials · 23% recruiting
- Massachusetts Eye and Ear Infirmary · 73 trials · 27% recruiting
- Tulane University · 73 trials · 30% recruiting
Sponsors near 10% open enrollment (± trial volume)
- Children's Oncology Group · 10% recruiting · 342 trials
- Apellis Pharmaceuticals · 10% recruiting · 21 trials
- Hologic · 10% recruiting · 21 trials
- Southern Illinois University · 10% recruiting · 21 trials
Related
What to do with this Joslin Diabetes Center page
73 registered trials is a research-attention snapshot, not an endorsement of Joslin Diabetes Center or any single study.
- 7 of Joslin Diabetes Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Hypoglycemia is the condition Joslin Diabetes Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hypoglycemia trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Joslin Diabetes Center pipeline card: 73 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.